House Health Subcommittee Examines Physician Payment Reform
The House Energy and Commerce Committee’s Health Subcommittee is holding a hearing to scrutinize the Medicare Physician Fee Schedule (PFS) and the reforms introduced by MACRA. Lawmakers and medical leaders will discuss persistent payment instability, especially for surgical and specialty providers, and the impact of budget‑neutrality adjustments that favor primary care. The American College of Surgeons argues that recent efficiency assumptions are flawed, citing data showing longer operative times and higher patient complexity. The hearing follows a series of hearings on affordability and could shape future payment policy.
Cedars-Sinai Deploys OpenEvidence Enterprise Platform to Drive Precision Clinical Decision Support
Cedars‑Sinai has rolled out the OpenEvidence enterprise platform across its entire network, embedding an AI‑driven clinical reference tool directly into the electronic health record. The system surfaces patient‑specific, peer‑reviewed medical literature at the point of care, while also allowing the...
Senate Democrats Move to Roll Back Medicare AI Prior Authorization Pilot
Senate Democrats introduced a resolution under the Congressional Review Act to terminate the Wasteful and Inappropriate Service Reduction (WISeR) model, an AI‑driven prior‑authorization pilot in Medicare. The pilot, active in six states, forces prior approval for services such as skin...
Hospital Device Security Cannot End at Visibility
Modern hospitals now run hundreds of thousands of connected medical, IoT and OT devices, making device visibility a top priority. A recent Asimily survey found 43 % of North American CISOs cite complete visibility as their biggest challenge, yet visibility alone...
WVE-006 RNA Editing Therapy Achieves MZ-Like Phenotype in Alpha-1 Antitrypsin Deficiency Phase 1b/2a Trial
Wave Life Sciences reported that its investigational RNA‑editing drug WVE‑006 generated major‑variant alpha‑1 antitrypsin (M‑AAT) levels comparable to the protective heterozygous Pi*MZ phenotype in patients with homozygous Pi*ZZ AAT deficiency. The Phase 1b/2a RestorAATion‑2 trial showed 64%–59% of circulating AAT was...
The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-Escalation
Boston Children’s Hospital has spent over a decade deploying AI‑driven clinical intelligence in its pediatric ICUs, shifting the focus from early‑warning alerts to data‑backed de‑escalation. Continuous, high‑frequency physiologic monitoring now provides real‑time risk trajectories that inform decisions on extubation and...
EQS-News: GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms
GeoVax Labs warned that the escalating Bundibugyo Ebola outbreak in Central Africa highlights the lack of licensed vaccines for less‑common Ebola strains. The company pointed to its Modified Vaccinia Ankara (MVA) platform, which has shown single‑dose protection against Zaire and...
When the Referee Owns the Team — and Tennessee Changes the Rules
Senate Bill 2040, soon to be signed by Governor Bill Lee, requires pharmacy benefit managers (PBMs) in Tennessee to separate from any pharmacies they own, ending vertical integration that can create conflicts of interest. The legislation targets practices such as...
DHSC Publishes Equality Impact Assessment for the Single Patient Record
Britain’s Department of Health and Social Care released an equality impact assessment for the proposed Single Patient Record (SPR) legislation in the Health Bill. The assessment, based on 2,200 public responses, shows more than three‑quarters of respondents back the SPR,...
The Compliance Bottleneck in Connected Health: Why Cloud-Based Medical Devices Need a Different V&V Approach
Traditional verification and validation (V&V) frameworks assume a static medical device, but cloud‑based platforms continuously evolve, creating a compliance bottleneck. The FDA’s emerging guidance—such as the Pre‑Determined Change Control Plan—offers a pathway for iterative updates but adds significant upfront documentation....
HHS Reorganizes Office for Civil Rights with Religious Bent
The Department of Health and Human Services is reorganizing its Office for Civil Rights, reinstating the Conscience and Religious Freedom Division that was eliminated in 2023. The OCR will now operate three distinct units: civil‑rights enforcement, health‑information privacy and cybersecurity,...
Surescripts Expands Prior Authorization Automation: Slashing Prescription Approval Times as New CMS Interoperability Rules Loom
Surescripts has broadened its Prior Authorization Automation platform, adding 68,000 prescribers across 42 health systems—a 50% increase since December 2025. The automated workflow now delivers a median approval time of just 18 seconds, eliminating manual forms, faxes, and calls. Real‑time...
Big Pharma Is Gambling on Specialized R&D. Will It Pay Off?
Big pharmaceutical firms are pivoting from broad, diversified pipelines to highly specialized research areas to offset looming revenue gaps from patent expirations and the Inflation Reduction Act’s shortened drug earnings life. Companies such as AstraZeneca are concentrating on nucleic‑acid therapeutics,...
How AI & CMS Are Solving the $4 Trillion Healthcare Crisis
The CMS ACCESS model, effective later in 2025, replaces fee‑for‑service Medicare payments with outcome‑aligned reimbursements, rewarding improvements in A1c and blood pressure rather than provider time. This shift opens a market of roughly 35 million Medicare beneficiaries to AI‑driven digital health...
Why Patient Engagement Is Clinical Trials’ Next Strategic Frontier
The article argues patient engagement is the next strategic priority for clinical trials, especially as decentralized and hybrid models reduce face‑to‑face contact. Simple reminder emails are insufficient; effective engagement requires tailored gamification, real‑time financial incentives, and transparent feedback showing participants...
Scientists Discover Why Alzheimer’s Risk Hits Women so Much Harder
Scientists at UC San Diego analyzed data from over 17,000 adults and found that several modifiable dementia risk factors have a disproportionately larger impact on women’s cognition than men’s. Women reported higher rates of depression, inactivity and sleep problems, while...
Treating Pattern Hair Loss: How Close Are We?
VeraDermics’ oral minoxidil pill VDPHL01 cleared a pivotal phase 2/3 trial, showing a 30‑33 hairs/cm² increase in non‑vellus hair count versus 7.3 for placebo and coverage improvement in over 79% of participants. The extended‑release formulation reduces peak blood levels that have...
Should You Trust Your Health to a Chiropractor?
The piece examines how chiropractic care has shifted from a fringe practice to a mainstream component of U.S. health services, noting that roughly 11 percent of American adults visited a chiropractor in 2022, primarily for pain management. National back‑pain guidelines now...
Scientists Found a Hidden Alzheimer’s Trigger and Shut It Down
Researchers at Indiana University identified the brain enzyme IDOL as a promising new target for Alzheimer’s therapy. Deleting IDOL from neurons in mouse models dramatically cut amyloid plaque buildup and lowered APOE levels, a key genetic risk factor. The findings...
AI Scribe Note Quality Under Question as Adoption Grows
AI-powered clinical scribes are gaining traction as a solution to physician documentation overload, but a new vendor‑neutral study published in JAMA Network Open finds the AI‑generated notes lag behind clinician‑written ones in thoroughness, organization, and clinical usefulness. Researchers evaluated 11...
Rerouting Dead Tumor Debris Enhances Cancer Immunotherapy Outcomes
Researchers at the Crick Institute have engineered antibodies that bind F‑actin exposed on dead tumor cells and redirect it to Fcγ receptors on abundant immune cells. This rerouting enables non‑specialized cells to present a wider array of tumor antigens, provoking...
NCCN Reinforces Global Commitment to Cancer-Related Distress Resources in Observance of Mental Health Awareness Month
The National Comprehensive Cancer Network (NCCN) has upgraded its Distress Thermometer, now offering the screening tool in more than 70 languages. The one‑page, 0‑to‑10 scale helps clinicians quickly identify psychological, physical, social and spiritual distress in cancer patients. Over 7,000...
Surprising Ways to Reduce Turnover in High-Pressure, High-Skill Jobs
In 2024, more than 287,000 U.S. staff nurses quit and roughly 1.6 million plan to leave within five years, creating a severe staffing crisis. A 26‑month study of 420 ICU nurses identified two powerful retention levers: assigning meaningful primary responsibility and...
Beam One-Ups Wave as Both Show Promise of Editing for AATD
Beam Therapeutics presented Phase 1/2 data for its DNA editor BEAM‑302, showing an 80% drop in mutated alpha‑1 antitrypsin (AAT) protein and lifting total AAT above the 11 µM protective threshold, with effects lasting 12 months. Wave Life Sciences reported its RNA editor...
Mirum Pharma: A Rare Disease Growth Story to Watch
Mirum Pharmaceuticals reported Q1 2026 revenue of $521.3 million, a 43% year‑over‑year increase, driven primarily by its lead drug Livmarli, which posted $159.9 million in net product sales. The company lifted its full‑year revenue guidance to $660‑$680 million, representing a 26% YoY rise, while...
AbbVie’s New Immunology Standard-Bearer Skyrizi Kneels to UCB’s Bimzelx in Psoriatic Arthritis
UCB’s Bimzelx outperformed AbbVie’s Skyrizi in a Phase 3 head‑to‑head trial for psoriatic arthritis, achieving 49.1% ACR50 versus 38.4% for Skyrizi at week 16. While Bimzelx also showed numerically higher minimal disease activity (43% vs 39.9%), the difference missed statistical significance. Skyrizi...
University Hospitals Sussex 2026/27 Digital Workplan Highlights AI, Patient Communications, Cloud, Research
University Hospitals Sussex NHS Foundation Trust released its 2026/27 digital workplan, spotlighting a structured AI rollout, enhanced patient communications, and a green‑focused cloud migration strategy. An AI governance group and draft policy have been created, but the board notes limited...
Seventy-Ninth World Health Assembly Honours Global Champions Advancing Primary Health Care
The World Health Assembly honored six individuals and institutions for advancing primary health care and reducing health inequities. The laureates—representing Mali, Thailand, France, Singapore, Bangladesh and Egypt—received the Sasakawa, UAE, Kuwait, Dr Lee Jong‑wook, and Nelson Mandela awards. The 2026 ceremony...
Sensome Reports the INSPECT Study Results of Its In Situ Tumor Detection Technology for Lung Cancer
Sensome disclosed first‑in‑human data from its INSPECT study, evaluating a microsensor‑enabled smart stylet for bronchoscopic lung biopsies in 27 patients across Australia and France. The device records tissue electrical signatures immediately before sampling, allowing real‑time differentiation of healthy, necrotic and...
Hiltzik: Justice Department Attack on UCLA and Other Med Schools Shows It Has No Idea What Makes a Good Doctor
The Justice Department sent letters to UCLA and Yale medical schools accusing them of using race as a factor in admissions, claiming the practice violates a 2023 Supreme Court ruling on racial preferences. The article contends the DOJ’s analysis is...
Governance Serves as Foundation in Healthcare Transformation
Employers are overpaying roughly $4,000 per employee each year on health benefits, and the first remedy is robust governance. The article urges advisers to transition from a transactional "retailer" role to a fiduciary "guardian" by establishing a dedicated health‑plan committee....
Why ICD-10 Coding Accuracy Has Become Critical in Modern Healthcare Operations
ICD-10 coding accuracy has become a linchpin for modern healthcare operations, influencing everything from claim approvals to analytics and compliance. Hospitals now scrutinize documentation quality, denial patterns, and reimbursement performance, making coding a strategic function rather than a clerical task....
BioMarin’s ENERGY 3 Trial of BMN 401 Meets One Co-Primary Endpoint
BioMarin Pharmaceutical announced that its Phase III ENERGY 3 trial of BMN 401 met one of two co‑primary endpoints, showing a statistically significant rise in plasma inorganic pyrophosphate (PPi) levels in children with ENPP1 deficiency through week 52. The trial failed to demonstrate any...
Why Healthcare Facilities Are Rethinking Disposable Glove Procurement
Healthcare providers are overhauling disposable glove procurement after the COVID‑era PPE shortage exposed supply‑chain fragility. Procurement teams now weigh vendor reliability, FDA and ASTM compliance, and ESG reporting alongside unit price. Biodegradable nitrile gloves that meet the same performance standards...
Medicaid Home-Based and Community-Based Services Long-Term Care Expenditures
The Balancing Incentive Program (BIP), created under the 2010 Affordable Care Act, offered states financial incentives to expand Medicaid home‑based and community‑based services (HCBS). Researchers compared 17 BIP‑participating states with a synthetic control of 17 non‑participating states using state‑level long‑term...
How AI Full Arch Implant Planning Is Changing Oral Surgery
AI-driven full‑arch implant planning is reshaping oral surgery by automating the traditionally labor‑intensive workflow. UK‑based 21D delivers an end‑to‑end system that handles 98% of planning from CBCT scan to surgical guide without a technician, claiming ~100 µm placement accuracy—about ten times...
Tuneable Peptide Biotech Parabilis Files IPO
Parabilis Medicines, the Cambridge‑based tuneable peptide biotech, filed a Nasdaq prospectus to raise roughly $100 million in an IPO under the PBLS ticker. The offering follows a $305 million private round and a multi‑billion‑dollar alliance with Regeneron, which contributed $50 million upfront and...
Eight Swedish Companies Spearheading the Country’s Biotech Scene in 2026
Sweden’s life‑science sector, now worth roughly $42 billion in turnover and employing over 52,000 people, is being propelled by eight standout biotech firms. Annexin Pharmaceuticals reported safety and early efficacy in a phase 2a ophthalmology trial, while Anocca raised $46 million to advance...
Lilly Snaps up Engage to Advance Non-Viral Genetic Medicines
Eli Lilly agreed to acquire Engage Biologics for up to $202 million in cash, adding the company’s non‑viral DNA delivery platform called Tethosome. The technology combines lipid‑nanoparticle shells with an mRNA‑encoded transport protein to move genetic payloads into cell nuclei without viral vectors....
Endologix Buys Clot Removal System From Surmodics
Endologix announced the acquisition of the Pounce peripheral thrombectomy system from Surmodics for an undisclosed price. Pounce, cleared by the FDA in 2020 and expanded with a larger version in 2024, uses dual nitinol baskets and a funnel to mechanically...
Solving the “Whac-A-Mole Dilemma”: A Smarter Way to Debias AI Vision Models
MIT, WPI, and Google researchers introduced Weighted Rotational DebiasING (WRING), a new post‑processing technique for vision‑language models. WRING rotates bias‑laden dimensions in the embedding space rather than projecting them out, preserving other learned relationships. In tests on CLIP‑style models, WRING...
South Tyneside and Sunderland Highlights RPA for GP Referrals
South Tyneside and Sunderland NHS Foundation Trust reports that robotic process automation (RPA) has accelerated GP referral handling, with 77% of patients receiving planned treatment within 18 weeks—well above the 63.5% national average. Digital workers now make referrals available to...
Radiology Associates of North Texas Says It Will Waste over $51M on Costs Related to No Surprises Act
Radiology Associates of North Texas (RANT), the nation’s largest independent imaging group, says it will incur more than $51 million in administrative expenses tied to the No Surprises Act. The practice estimates it must file 68,000 arbitration batches, each costing $115...
Efficacy of Ustekinumab Combined with Partial Enteral Nutrition in Crohn’s Disease
A retrospective cohort of 124 Crohn’s disease patients showed that adding partial enteral nutrition (PEN) to ustekinumab (UST) therapy markedly improved long‑term mucosal healing. At week 54, endoscopic remission was achieved in 71.05% of the UST + PEN group versus 50.00% with...
West Hertfordshire Teaching Hospitals Shares Latest on AI Projects, UTC Integration, EPR Optimisation
West Hertfordshire Teaching Hospitals NHS Trust reported significant digital advances at its May board meeting, including the digitisation of ambulance handovers and the rollout of Cerner for its urgent treatment centre. The trust completed its HYDE ambient‑voice AI contract and...
Radiologists, Other Docs Quitting Clinical Practice Earlier and for Different Reasons than Before
New AMA research shows radiologists and other physicians are leaving clinical practice earlier than in past generations. The average age of departure is now 48 years, roughly nine years younger than the 57‑year average reported in 2008. “Hassle factor” and...
UCB Reports P-III (BE BOLD) Trial Data on Bimzelx in Active Psoriatic Arthritis
UCB disclosed Phase III BE BOLD trial results comparing its Bimzelx (bimekizumab) to AbbVie’s Skyrizi (risankizumab) in 553 adults with active psoriatic arthritis. The primary endpoint was met, with 49.1% of patients achieving an ACR50 response at week 16 versus 38.4%...
East of England Adult Critical Care Network Partners with Mela Solutions on Analytics Project
The East of England Adult Critical Care Network has teamed up with analytics firm Mela Solutions to launch a shared data platform. The system now contains over 220,000 admissions and 1.2 million assessment days, and early analysis shows a notable reduction...
Plantwatch: How Goat’s Rue Inspired Super Drug for Everything From Diabetes to Obesity
Goat’s rue (Galega officinalis) long served as a folk remedy for diabetes, its active molecule galegine lowering blood glucose but causing toxicity. Chemists later transformed galegine into metformin, a synthetic analogue that retains glucose‑lowering power without the harmful side effects....
Diphtheria Is Spreading in Australia and so Is Misinformation About It
Australia is experiencing a diphtheria outbreak that has reached several states and territories, with one confirmed death in the Northern Territory. The disease, once curbed by 1930s vaccination campaigns, is resurging in remote Aboriginal communities where immunisation rates have slipped....